In the context of de novo glioblastoma, a highly aggressive brain cancer, ADAR2-mediated editing of miR-589-3p results in a shift from its regulation of the tumor suppressor PCDH9 to the modulation of ADAM12, effectively impeding glioblastoma invasion 42. The gene discussed is PCDH9; the disease is neoplasm.